English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/207652
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis

AuthorsMestre, Leyre ; Carrillo-Salinas, Francisco J; Mecha, Miriam ; Feliú, Ana; Espejo, Carmen; Álvarez-Cermeño, José C.; Villar, Luisa María; Guaza, Carmen
KeywordsTheiler's virus model
gut microbiota
Treg and Breg cells
multiple sclerosis
Issue Date2019
PublisherFrontiers Media
CitationFrontiers in Immunology 10: 1374 (2019)
AbstractGut microbiota dysbiosis has been implicated in MS and other immune diseases, although it remains unclear how manipulating the gut microbiota may affect the disease course. Using a well-established model of progressive MS triggered by intracranial infection with Theiler's murine encephalomyelitis virus (TMEV), we sought to determine whether dysbiosis induced by oral antibiotics (ABX) administered on pre-symptomatic and symptomatic phases of the disease influences its course. We also addressed the effects of microbiota recolonization after ABX withdrawn in the presence or absence of probiotics. Central and peripheral immunity, plasma acetate and butyrate levels, axon damage and motor disability were evaluated. The cocktail of ABX prevented motor dysfunction and limited axon damage in mice, which had fewer CD4+ and CD8+ T cells in the CNS, while gut microbiota recolonization worsened motor function and axonal integrity. The underlying mechanisms of ABX protective effects seem to involve CD4+CD39+ T cells and CD5+CD1d+ B cells into the CNS. In addition, microglia adopted a round amoeboid morphology associated to an anti-inflammatory gene profile in the spinal cord of TMEV mice administered ABX. The immune changes in the spleen and mesenteric lymph nodes were modest, yet ABX treatment of mice limited IL-17 production ex vivo. Collectively, our results provide evidence of the functional relevance of gut microbiota manipulation on the neurodegenerative state and disease severity in a model of progressive MS and reinforce the role of gut microbiota as target for MS treatment.
Publisher version (URL)http://dx.doi.org/10.3389/fimmu.2019.01374
Identifiersdoi: 10.3389/fimmu.2019.01374
issn: 1664-3224
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
765450.pdf3,3 MBUnknownView/Open
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.